From: Muscle loss phenotype in COPD is associated with adverse outcomes in the UK Biobank
Factor | Any MLP criteria | By BMI | By HGS | By FFMI | By ASMI | |||||
---|---|---|---|---|---|---|---|---|---|---|
HR (95% CI) | p-value | HR (95% CI) | p-value | HR (95% CI) | p-value | HR (95% CI) | p-value | HR (95% CI) | p-value | |
MLP | 1.7 (1.5, 2.0) | < 0.001 | 2.2 (1.5, 3.3) | < 0.001 | 1.6 (1.4, 1.9) | < 0.001 | 2.0 (1.7, 2.4) | < 0.001 | 1.7 (1.4, 2.0) | < 0.001 |
Male vs. Female | 1.4 (1.2, 1.7) | < 0.001 | 1.6 (1.4, 1.9) | < 0.001 | 1.7 (1.5, 2.0) | < 0.001 | 1.6 (1.4, 1.9) | < 0.001 | 1.2 (1.02, 1.4) | 0.029 |
Age (years) | 1.1 (1.09, 1.1) | < 0.001 | 1.1 (1.1, 1.1) | < 0.001 | 1.1 (1.10, 1.1) | < 0.001 | 1.1 (1.10, 1.1) | < 0.001 | 1.1 (1.10, 1.1) | < 0.001 |
BMI (1 kg/m2 increment) | 1.04 (1.03, 1.06) | < 0.001 | - | - | 1.02 (1.01, 1.04) | 0.005 | 1.05 (1.03, 1.06) | < 0.001 | 1.06 (1.04, 1.08) | < 0.001 |
British vs. Other Ethnicity | 0.85 (0.65, 1.1) | 0.240 | 0.84 (0.65, 1.10) | 0.200 | 0.87 (0.66, 1.1) | 0.310 | 0.86 (0.65, 1.1) | 0.250 | 0.84 (0.64, 1.09) | 0.190 |
Cancer diagnosed by doctor | 0.98 (0.78, 1.2) | 0.88 | 0.97 (0.77, 1.2) | 0.81 | 0.98 (0.78, 1.2) | 0.84 | 0.99 (0.79, 1.2) | 0.96 | 0.99 (0.79, 1.2) | 0.92 |
Current alcohol use | 0.62 (0.50, 0.76) | < 0.001 | 0.60 (0.49, 0.74) | < 0.001 | 0.62 (0.51, 0.77) | < 0.001 | 0.60 (0.49, 0.73) | < 0.001 | 0.61 (0.49, 0.74) | < 0.001 |
Current smoker | 4.6 (4.0, 5.2) | < 0.001 | 4.4 (3.8, 5.0) | < 0.001 | 4.6 (4.0, 5.2) | < 0.001 | 4.5 (3.9, 5.1) | < 0.001 | 4.5 (4.0, 5.2) | < 0.001 |
FEV1/FVC ratio (0.1 unit increment) | 0.45 (0.42, 0.47) | < 0.001 | 0.45 (0.43, 0.47) | < 0.001 | 0.45 (0.42, 0.47) | < 0.001 | 0.44 (0.42, 0.47) | < 0.001 | 0.44 (0.42, 0.47) | < 0.001 |